Close
Help




JOURNAL

Clinical Medicine Insights: Ear, Nose and Throat

Fas and Cancer

Submit a Paper


Clinical Medicine Insights: Ear, Nose and Throat 2010:3 1-4

Commentary

Published on 07 Apr 2010

DOI: 10.4137/CMENT.S3147


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Ear, Nose and Throat

Abstract

Apoptosis is an active process of programmed cell death. Fas is a cell-surface protein which is expressed on activated lymphocytes and known as CD95, TNFRSF6 or APO-1. Fas-L is ligand of Fas and known as CD95 LG or TNFSF6. Apoptosis or cell death is a result of binding of Fas-L to Fas which is expressed on the surfaces of these cells. Cancer cells escape this binding by over-expression of Fas-L or down expression of Fas. Fas and Fas-L exist in membrane bound and soluble forms. The serum level of sFas and sFas-L can be evaluated by immunostaining, immunohistochemical methods, immunofluorescence, flow cytometry and Western blotting. Head and neck squamous cell carcinoma diagnosis, staging and prognosis can be evaluated early and accurately by sFas and sFas-L expression levels detection.



Downloads

PDF  (425.63 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)


Sharing


What Your Colleagues Say About Clinical Medicine Insights: Ear, Nose and Throat
This is the most author-friendly editing process I have experienced.  The publishing process of this journal was a most pleasant and productive experience and it was fast and convenient.
Professor Amira Helmy PhD (Theodor Bilharz Research Institute, Egypt)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube